KL
Kalbe Farma
KLBF.JK·IDXJakarta IDFounded 196617,000 employees
Mid CappharmaPublicOncologyGI
Platform: SE Asia Pharma
Market Cap
$5B
All Drugs
3
Clinical Trials
5
Failed / Terminated
1
FDA Approved
0
Stock Price & Catalysts (KLBF.JK)
Loading KLBF.JK stock data...
Drug Pipeline (3 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| KLB-5656 | KLB-5656 | Phase 1 | 1 | GLP-1R | Cholangiocarcinoma | ||
| KLB-9971 | KLB-9971 | Phase 1/2 | 1 | SOS1 | DMD | ||
| Mavumavacamten | KLB-8056 | Phase 3 | 3 | DLL3 | MDS |
SEC Filings & Financial Documents
SEC filings are not available for IDX-listed companies.
Kalbe Farma trades on IDX (ID). SEC EDGAR only covers US-listed issuers.
Insider Trading Activity
Insider trading data is not available for non-US exchanges.
Catalyst Events (4)